When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Authors: Anne-Marie Baird, David Easty, Monika Jarzabek, Liam Shiels, Alex Soltermann, Sonja Klebe, Stéphane Raeppel, Lauren MacDonagh, Chengguang Wu, Kim Griggs, Michaela B. Kirschner, Bryan Stanfill, Daisuke Nonaka, Chandra M. Goparaju, Bruno Murer, Dean A. Fennell, Dearbhaile M. O'Donnell, Martin P. Barr, Luciano Mutti, Glen Reid, Stephen Finn, Sinead Cuffe, Harvey I. Pass, Isabelle Opitz, Annette T. Byrne, Kenneth J. O'Byrne, Steven G. Gray

Source: Frontiers in Endocrinology, Vol 10 (2019)

Subject Terms: Malignant Pleural Mesothelioma, RON, MET, TAM, RTK, MST1, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fendo.2019.00089/full; https://doaj.org/toc/1664-2392

Access URL: https://doaj.org/article/567be960042e4cd789610ded3489753b